NEOGENOMICS INC — Director's Dealing 2019

Nov 14, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2019-11-12

Reporting Person: CARDOZA GEORGE (President, Pharma Services)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-12	Common Stock	M	44444	$7.15	Acquired	345275	Direct
2019-11-12	Common Stock	S	19444	$23.15	Disposed	325831	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-11-12	Stock Option (Right to Buy)	$7.15	M	44444	Disposed	2021-04-20	Common Stock (44444.0)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$7.52	2022-04-28	Common Stock (200000.0)	200000	Direct
Stock Options (Right to Buy)	$8.03	2023-02-26	Common Stock (192500.0)	192500	Direct
Stock Option (Right to Buy)	$19.6	2024-03-01	Common Stock (51459.0)	51459	Direct

Footnotes

F1: On April 20, 2016, Mr. Cardoza was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F2: On April 28, 2017, Mr. Cardoza was granted 200,000 stock options. These options vest ratably over the next three anniversary dates of the grant date.

F3: On February 26, 2018, Mr. Cardoza was granted 192,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F4: On March 1, 2019, Mr. Cardoza was granted 51,459 stock options. These options vest ratably over the first four anniversary dates of the grant.